FDA Proposes New Restrictions on Compounding Weight-Loss Drugs from Novo and Lilly

FDA Proposes New Restrictions on Compounding Weight-Loss Drugs from Novo and Lilly

New Regulations Target Compounding Practices The U.S. Food and Drug Administration proposed new regulations aimed at curbing the mass compounding of...